Patrick Fowler

Patrick joined Vericel in 2021 with over 15 years of business development, strategy and operations experience in the biotechnology and medical technology industries and an established history of guiding corporate and business unit strategies across a variety of therapeutic area franchises. Prior to joining Vericel, Patrick served as Head, North America Strategy, Operations & New Product Development for Sanofi, formerly Genzyme Corporation, where he led the business development, lifecycle management and go-to market strategy efforts for General Medicines and Established Products. During his tenure at Sanofi, Patrick also served as Head, North America Business Development, Specialty Care as well as Head of Biosurgery Business Development & Portfolio Strategy. Previously, Patrick served in a number of corporate development roles at Genzyme. Patrick earned a B.S., cum laude, in Molecular Genetics and Cell Biology from the University of Minnesota and an M.B.A. from the University of Toronto.